Stock Report Johnson & Johnson with In-Depth Stock Analysis

Johnson & Johnson XNYS: JNJ

Mid-range Performer

164.58 9.41 (6.06%)

19.2M

XNYS Volume

XNYS 16 Jul, 2025 3:58 PM (EDT)

Estimates Beat

Johnson & Johnson's Q2 revenue beats estimates by 3.9% led by higher sales in MedTech segment See details

Detailed Stock Analysis for Johnson & Johnson with Real-time Stock Report